LexaGene has partnered with Boston Engineering to develop the technology and to assist in accelerating the product to market. In addition, Boston Engineering is a major shareholder.

Since 1995, the company’s multidisciplinary teams have been creating devices that diagnose human illness, improve lifesaving care, and advance the surgical suite. Boston Engineering’s ISO 13485 and ISO 9001 certifications underscore its quality management system for product design and development in medical devices and other industries. The company has worked with the Department of Homeland Security, the US Navy, and National Oceanic and Atmospheric Administration. Boston Engineering provides product design and engineering consulting across the entire product development process – from concept through commercialization to improve how people work and live.

Lawrence Livermore National Laboratory

US National security laboratory whose science and engineering are being applied to achieve breakthroughs for counterterrorism and nonproliferation, defense and intelligence, energy and environmental security.

LexaGene’s technology represents an advancement over three previously developed automated instruments that were built using ~ $20M USD in government funding at Lawrence Livermore National Laboratory. One of these instruments was built to detect bio-warfare agents after 9/11 and became part of the Department of Homeland Security’s BioWatch Program. Another was used to rapidly detect eight respiratory pathogens, such as influenza and RSV.

LexaGene aims to continue an LLNL tradition of having exciting technologies developed at the Laboratory go on to become commercially successful. Other success stories include: